Sichuan Kelun Pharmaceutical Hits Day High with 5.45% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a notable increase of 5.45% on March 10, 2026, reaching an intraday high of CNY 34.07. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.65% on the same day. Over the past week, Sichuan Kelun has shown a robust performance with a 13.96% increase, significantly outpacing the composite index's minimal growth of 0.01%. Despite these short-term gains, the company has faced challenges in its financial metrics. Over the last year, Sichuan Kelun's stock has generated a return of only 2.94%, lagging behind the China Shanghai Composite's impressive 21.47%. The company reported a decline in net sales of 15.48% and has posted negative results for the last two consecutive quarters. With a market capitalization of CNY 36,978 million, Sichuan Kelun operates within the pharmaceuticals and biotechnology sector, boasting a P/E ratio of 26.00 and a dividend yield of 2.41%. However, its return on equity stands at 7.03%, indicating areas for improvement in financial performance.